Atara Biotherapeutics (ATRA) Revenue Growth (1y) (2022 - 2026)
Atara Biotherapeutics (ATRA) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,824.80 Bn | 1,824.74 Bn | - | - |
| 2 | Akari Therapeutics | 955.99 Bn | 955.99 Bn | - | - |
| 3 | BeOne Medicines | 473.90 Bn | 469.11 Bn | 1.35 Bn | 35.46% |
| 4 | Vertex Pharmaceuticals | 123.79 Bn | 116.54 Bn | 2.59 Bn | 7.82% |
| 5 | Regeneron Pharmaceuticals | 71.64 Bn | 62.88 Bn | 3.31 Bn | 19.04% |
| 6 | Belite Bio | 62.78 Bn | 62.78 Bn | - | - |
| 7 | Argenx Se | 55.45 Bn | 50.27 Bn | 1.41 Bn | 64.03% |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 96.43% |
| 9 | Revolution Medicines | 37.16 Bn | 37.16 Bn | - | - |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 | -99.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.47% |
| Dec 31, 2025 | -95.13% |
| Sep 30, 2025 | -91.41% |
| Jun 30, 2025 | -38.63% |
| Mar 31, 2025 | 258.77% |
| Dec 31, 2024 | 1,188.14% |
| Sep 30, 2024 | 1,889.60% |
| Jun 30, 2024 | 17,363.41% |
| Mar 31, 2024 | 2,994.68% |
| Dec 31, 2023 | -269.77% |
| Sep 30, 2023 | -54.70% |
| Jun 30, 2023 | -99.68% |
| Dec 31, 2022 | -76.51% |
| Sep 30, 2022 | -16.96% |
| Jun 30, 2022 | 1,232.79% |